217 related articles for article (PubMed ID: 28239141)
1. Chronic Myeloid Leukemia Associated Hypercalcemia: A Case Report and Literature Review.
Toro-Tobón D; Agosto S; Ahmadi S; Koops M; Bruder JM
Am J Case Rep; 2017 Feb; 18():203-207. PubMed ID: 28239141
[TBL] [Abstract][Full Text] [Related]
2. [Hypercalcemia associated with blast crisis of chronic myeloid leukemia].
Murata T; Motomura S; Harano H; Kanamori H; Miyasita H; Ogawa K; Ookubo T
Rinsho Ketsueki; 1990 Feb; 31(2):177-82. PubMed ID: 2184269
[TBL] [Abstract][Full Text] [Related]
3. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia as the presenting feature of t-cell lymphoid blast crisis of ph-positive chronic myeloid leukemia.
Nadal E; Cervantes F; Rosiñol L; Talarn C; Montserrat E
Leuk Lymphoma; 2001 Mar; 41(1-2):203-6. PubMed ID: 11342375
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia in the blastic phase of chronic myeloid leukemia associated with elevated parathyroid hormone-related protein.
Seymour JF; Grill V; Martin TJ; Lee N; Firkin F
Leukemia; 1993 Oct; 7(10):1672-5. PubMed ID: 8412332
[TBL] [Abstract][Full Text] [Related]
6. Extensive bone marrow necrosis and symptomatic hypercalcemia in B cell blastic transformation of chronic myeloid leukemia: report of a case and review of the literature.
Noguchi M; Oshimi K
Acta Haematol; 2007; 118(2):111-6. PubMed ID: 17641550
[TBL] [Abstract][Full Text] [Related]
7. Leukemic arthritis and severe hypercalcemia in a man with chronic myeloid leukemia: a case report and review of the literature.
Rujirachun P; Junyavoraluk A; Owattanapanich W; Suvannarerg V; Sirinvaravong S
J Med Case Rep; 2018 Sep; 12(1):257. PubMed ID: 30196795
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature.
Kolyva S; Efthymiadou A; Gkentzi D; Karana-Ginopoulou A; Varvarigou A
J Pediatr Endocrinol Metab; 2014 Mar; 27(3-4):349-54. PubMed ID: 23934636
[TBL] [Abstract][Full Text] [Related]
9. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
10. Modern management of malignant hypercalcemia.
Legrand SB
Am J Hosp Palliat Care; 2011 Nov; 28(7):515-7. PubMed ID: 21724679
[TBL] [Abstract][Full Text] [Related]
11. Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
[TBL] [Abstract][Full Text] [Related]
12. [Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy].
Tomoo T; Suzuki M
Nihon Yakurigaku Zasshi; 2005 Nov; 126(5):353-7. PubMed ID: 16394581
[No Abstract] [Full Text] [Related]
13. [A case report of a patient treatable by home palliative care, administered zoledronic acid used for bladder cancer with hypercalcemia].
Murakami N; Tanabe K; Murasugi K; Kadoya S; Matsumoto Y; Yoshii I; Fujikawa Y; Ohura F
Gan To Kagaku Ryoho; 2010 May; 37(5):939-42. PubMed ID: 20495334
[TBL] [Abstract][Full Text] [Related]
14. Treatment of bisphosphonate-resistant hypercalcemia of malignancy with calcitonin.
Dawson C; Todd AM; Walton A
J Palliat Med; 2014 Oct; 17(10):1084. PubMed ID: 25265187
[No Abstract] [Full Text] [Related]
15. [Hypercalcemia mediated by parathyroid hormone-related protein in the blastic phase of chronic myelogenous leukemia].
Kakihana K; Mizuchi D; Yamaguchi M; Sakashita C; Fukuda T; Yamamoto K; Miki T; Tohda S; Koyama T; Murakami N; Miura O
Rinsho Ketsueki; 2002 Feb; 43(2):102-6. PubMed ID: 11925871
[TBL] [Abstract][Full Text] [Related]
16. Mismanagement of malignant hypercalcaemia.
Lightowlers S; Patterson D
Clin Med (Lond); 2013 Feb; 13(1):118. PubMed ID: 23472518
[No Abstract] [Full Text] [Related]
17. Use of imatinib mesylate for favorable control of hypercalcemia mediated by parathyroid hormone-related protein in a patient with chronic myelogenous leukemia at blast phase.
Miyoshi N; Tanaka H; Ito T; Katayama Y; Niimi H; Hyodo H; Kimura A
Int J Hematol; 2005 Nov; 82(4):333-7. PubMed ID: 16298826
[TBL] [Abstract][Full Text] [Related]
18. Rare association between penile squamous cell carcinoma and parathyroid related peptide (PTH-rP) secretion.
Trejo-Rosales R; Nevarez-Barragan MJ; Rosas-Jurado MG; Perez-Diaz I; Bezaury AP
Arq Bras Endocrinol Metabol; 2014 Aug; 58(6):646-9. PubMed ID: 25211448
[TBL] [Abstract][Full Text] [Related]
19. Bilineal Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review.
Gao X; Li J; Wang L; Lin J; Jin H; Xu Y; Wang N; Zhao Y; Liu D; Yu L; Wang Q
Am J Case Rep; 2016 Oct; 17():793-798. PubMed ID: 27784881
[TBL] [Abstract][Full Text] [Related]
20. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
